Article: Investor stand-off threatens Arana takeover.

Byline: Ari Sharp

May 11, 2009 (The Age - ABIX via COMTEX) -- US-based Cephalon has issued a supplementary bidder's statement for its hostile takeover move on fellow pharmaceuticals group Arana Therapeutics. The bid is unchanged at $A1.40 per share in cash, with a premium of $A0.05 if the predator gains more than 90% acceptances. An extension past the deadline of 1 June 2009 has been ruled out ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!